Advertisement

Embryonic Stem Cells as a Model for Studying Osteoclast Lineage Development

  • Toshiyuki Yamane
  • Takahiro Kunisada
  • Shin-Ichi Hayashi
Part of the Methods in Molecular Biology™ book series (MIMB, volume 185)

Abstract

Osteoclasts are cells specialized to resorb bone (1,2). They originate from hematopoietic progenitors (3,4), which are widely distributed throughout the body. Osteoclast progenitors differentiate into cells that are positive for calcitonin receptor and tartrate-resistant acid phosphatase (TRAP), which are specific markers for this lineage, and then they fuse with each other and form fully functional multinucleated large cells (1,2) (Fig. 1). TRAP-positive osteoclasts are found tightly attached to bone matrix (1,2). Two cytokines, macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-κB (RANK) ligand (RANKL; also known as OPGL, ODF, and TRANCE), are known to be responsible for this differentiation (5, 6, 7). In this chapter, we describe the procedure for the induction of differentiation into the osteoclast lineage from murine embryonic stem (ES) cells (8). We utilize co-culture systems with stromal cell lines, that is, bone marrow-derived ST2 cells (9) or newborn calvaria-derived M-CSF-deficient OP9 cells (10). M-CSF is produced constitutively by ST2, and the expression of RANKL is induced on ST2 by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and dexamethasone (Dex) (6).
Fig. 1.

Scheme describing the development of osteoclast lineage. The essential molecules expressed in this lineage are indicated at the stage where maturation is arrested by the loss of function. The cells positive for TRAP are shaded.

Keywords

Embryonic Stem Cell Osteoclast Progenitor Embryonic Stem Cell Culture Undifferentiated Embryonic Stem Cell Embryonic Stem Cell Culture Medium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Mundy, G. R. and Roodman, G. D. (1987) Osteoclast ontogeny and function. Bone Miner. Res. 5, 209–279.Google Scholar
  2. 2.
    Suda, T., Udagawa, N., and Takahashi, N. (1996) Cells of bone: osteoclast generation, in Principles of bone biology (Bilezikian, J. P., Raisz, L. G., and Roden, G. A., eds.), Academic Press, New York, NY, pp. 87–102.Google Scholar
  3. 3.
    Ash, P., Loutit, J. F., and Townsend, K. M. (1980) Osteoclasts derived from haematopoietic stem cells. Nature 283, 669–670.PubMedCrossRefGoogle Scholar
  4. 4.
    Hayashi, S.-I., Yamane, T., Miyamoto, A., Hemmi, H., Tagaya, H., Tanio, Y, et al. (1998) Commitment and differentiation of stem cells to the osteoclast lineage. Biochem. Cell Biol. 76, 911–922.PubMedCrossRefGoogle Scholar
  5. 5.
    Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., et al. (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442–444.PubMedCrossRefGoogle Scholar
  6. 6.
    Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95, 3597–3602.PubMedCrossRefGoogle Scholar
  7. 7.
    Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165–176.PubMedCrossRefGoogle Scholar
  8. 8.
    Yamane, T, Kunisada, T., Yamazaki, H., Era, T, Nakano, T, and Hayashi, S. I. (1997) Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood 90, 3516–3523.PubMedGoogle Scholar
  9. 9.
    Ogawa, M., Nishikawa, S., Ikuta, K., Yamamura, F., Naito, M., Takahashi, K., and Nishikawa, S.-I. (1988) B cell ontogeny in murine embryo studied by a culture system with the monolayer of a stromal cell clone, ST2: B cell progenitor develops first in the embryonal body rather than in the yolk sac. EMBO J. 7, 1337–1343.PubMedGoogle Scholar
  10. 10.
    Kodama, H., Nose, M., Niida, S., Nishikawa, S., and Nishikawa, S.-I. (1994) Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp. Hematol. 22, 979–984.PubMedGoogle Scholar
  11. 11.
    Nakano, T., Kodama, H., and Honjo, T. (1994) Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265, 1098–1101.PubMedCrossRefGoogle Scholar
  12. 12.
    Yamane, T, Kunisada, T, Yamazaki, H., Nakano, T, Orkin, S. H., and Hayashi, S.-I. (2000) Sequential requirements for SCL/tal-1, GATA-2, M-CSF, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development. Exp. Hematol. 28, 833–840.PubMedCrossRefGoogle Scholar
  13. 13.
    Doetschman, T. C, Eistetter, H., Katz, M., Schmidt, W., and Kemler, R. (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27–45.PubMedGoogle Scholar
  14. 14.
    Li, E., Bestor, T. H., and Jaenisch, R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915–926.PubMedCrossRefGoogle Scholar
  15. 15.
    Robertson, E., Bradley, A., Kuehn, M., and Evans, M. (1986) Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 323, 445–448.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2002

Authors and Affiliations

  • Toshiyuki Yamane
    • 1
  • Takahiro Kunisada
    • 2
  • Shin-Ichi Hayashi
    • 1
  1. 1.Department of Immunology, School of Life Science, Faculty of MedicineTottori UniversityYonagoJapan
  2. 2.Department of Hygiene, Faculty of MedicineGifu UniversityGifuJapan

Personalised recommendations